Spruce Biosciences, Inc. (SPRB) stock
SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$43.31+0.42 (+0.98%)
Close on Nov 13, 2026Market cap $124.47MP/E –Yield –
Spruce Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Spruce Biosciences's price to sales ratio was 62.7× on Jan 30, 2026, against 163.6× a year earlier. Over the last 3 years it ranged from 1.6× to 238.4×, with a median of 22.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 62.7× | −7.7 |
| 2025 | Dec 31, 2025 | 70.4× | +68.0 |
| 2024 | Dec 31, 2024 | 2.4× | −14.1 |
| 2023 | Dec 29, 2023 | 16.6× | – |
See a number that looks wrong?